Cardiovascular

Latest News

Women holding up heart hands | Image credit: Studio Romantic – stock.adobe.com
Women Still Underrepresented in Key Cardiovascular Trials

September 11th 2025

From 2017 to 2023, women were especially underrepresented in trials in arrhythmia, coronary heart disease, acute coronary syndrome, and heart failure.

Empagliflozin bottle | Image credit: luchschenF – stock.adobe.com
Empagliflozin Shown to Reduce Endothelial Dysfunction in Women With INOCA

September 10th 2025

FDA approved. | Image Credit: Pawel - stock.adobe.com
FDA Expands Evolocumab Label for Adults With Increased MACE Risk From Uncontrolled LDL-C

August 25th 2025

Women are at a higher risk for developing cardiovascular disease or experiencing an adverse cardiovascular disease event if they've been stalked or obtained a restraining order. | Image Credit: AdobeStock_Joerch.jpeg
Stalking Associated With Higher Risk of CVD in Women

August 13th 2025

AJMC
Assessment of Variation in Ambulatory Cardiac Monitoring Among Commercially Insured Patients

August 13th 2025

Lipoprotein(a) and Cardiovascular Risk

Learn about more about lipoprotein(a), including how to improve patient outcomes through better screening and management.

AJMC Peer Exchange logo
Continuing Medical Education
View All
September 14th 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
September 14th 2025

Evidence-Based Guidelines Point to Leap in Care for Hypertrophic Cardiomyopathy

1.0 Credit / Cardiology
September 14th 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health
September 14th 2025

Driving Better Outcomes in Hypertrophic Cardiomyopathy: A Managed Care Imperative

1.5 Credits / Cardiology
September 14th 2025

The Evolving Landscape of Transthyretin Amyloidosis Cardiomyopathy: New Therapies and Treatment Strategies

1.5 Credits / Cardiology, Rare Diseases
September 14th 2025

Pulmonary Arterial Hypertension: Real-World Applications of New Therapies and Management Strategies

1.5 Credits / Pulmonology, Cardiology, Rare Diseases

More News

Familial Hypercholesterolemia | Image credit: Richelle – stock.adobe.com
September 23rd 2024

A Decade of Progress in Familial Hypercholesterolemia Awareness, Treatment

Hayden E. Klein
On day 1 of the Family Heart Global Summit, speakers highlighted the critical need for awareness, early diagnosis, and innovative treatment options for familial hypercholesterolemia, sharing significant strides made in the field over the past decade.
Denver Colorado | Image Credit: © f11photo - stock.adobe.com
September 16th 2024

Institute for Value-Based Medicine®: Multifaceted Approach Can Help Patients Benefit From the Expanded Lipid-Lowering Toolbox

Christina Mattina
Clinicians, researchers, and payer experts convened in Aurora, Colorado, on August 13, 2024, for discussions on ensuring that the recent advancements in lipid management are making their way to patients.
Family in hospital | Image Credit: LIGHTFIELD STUDIOS - stock.adobe.com
September 9th 2024

Spouses, Relatives of Patients With GU Cancer Face Elevated Cardiovascular, Psychological Comorbidity Risks

Brooke McCormick
Spouses and first-degree relatives of patients with genitourinary (GU) cancers face increased risks of developing cardiovascular and psychological comorbidities, particularly within the first year of diagnosis.
Dr Ty Gluckman
September 5th 2024

Dr Ty J. Gluckman on Cardiovascular Prevention Barriers, Exciting Therapy Developments for 2025

Brooke McCormick
Ty J. Gluckman, MD, FACC, FAHA, of Providence St. Joseph Health, emphasizes the need for better prevention of cardiovascular risks and discusses upcoming advances in glucagon-like peptide 1 (GLP-1) therapies.
Joseph Biggio, MD, system chair and service line leader for women's services, and system chair for maternal fetal medicine at Ochsner Health
September 3rd 2024

Ochsner Health's Connected MOM Program: Managing Hypertension During Pregnancy and Postpartum

Pearl Steinzor
Joseph Biggio, MD, system chair and service line leader for women's services and system chair for maternal fetal medicine at Ochsner Health, discusses some of the innovations to manage hypertension during pregnancy and postpartum.
dr ty gluckman
September 3rd 2024

CMS Negotiated Drug Prices: Cardiologist's View on Affordability, Future Innovation

Brooke McCormick
Ty J. Gluckman, MD, FACC, FAHA, of Providence St. Joseph Health, reacted positively to CMS' drug price cuts under the Inflation Reduction Act, but he also expressed concerns about the potential future impact on drug innovation.
Inclisiran's twice-yearly cadence and physician administration have potential to improve adherence to treatment, which is a common challenge with cholesterol management. Image credit: Robert - stock.adobe.com
August 30th 2024

Inclisiran Significantly Lowers LDL-C in V-MONO Study

Rose McNulty
Twice-yearly inclisiran (Leqvio) monotherapy showed clinically meaningful and statistically significant LDL-C lowering in patients at low or moderate risk of atherosclerotic cardiovascular disease in the V-MONO study.
Semaglutide Ozempic injection blood sugar obesity - myskin - stock.adobe.com.jpeg
August 26th 2024

Medicare Semaglutide Coverage: Millions May Gain Access That Could Cost $145 Billion

Giuliana Grossi
Medicare has not clearly defined what constitutes "established cardiovascular disease," leading to variability in potential patient eligibility; therefore, researchers aimed to estimate the number of Medicare beneficiaries who would become newly eligible for semaglutide under different definitions.
Dr Martha Gulati
August 26th 2024

Dr Martha Gulati Previews ESC 2024: Obesity, Heart Failure, and the Ongoing Debate on HRT

Giuliana Grossi
Martha Gulati, MD, Cedars-Sinai, discusses the topics expected to be featured at the European Society of Cardiology (ESC) Congress, including a debate she's participating in about the role of hormone replacement therapy (HRT) in primary cardiovascular disease prevention.
Human brain digital illustration | Image Credit: Siarhei - stock.adobe.com
August 14th 2024

Anti-Inflammatory Diet Linked to Lower Dementia Risk, Better Brain Health in Patients With Cardiometabolic Diseases

Brooke McCormick
Patients with cardiometabolic diseases who follow an anti-inflammatory diet have better brain health and a lower risk of dementia.
Joseph Biggio, MD, system chair and service line leader for women's services, and system chair for maternal fetal medicine at Ochsner Health
August 5th 2024

Ochsner Health Wins HHS Hypertension Innovator Award for Connected MOM Program

Pearl Steinzor
Ochsner Health's Connected Maternity Online Monitoring (MOM) program has been recognized for its innovative approach in managing hypertension during pregnancy and postpartum.
Cardiac CT scan | Image credit: Cleveland Clinic
August 3rd 2024

Using Imaging—and AI—to Find Those at Risk of Cardiac Events

Mary Caffrey
A joint session with the Society for Cardiovascular Computed Tomography (SCCT) took place on the first day of the American Society for Preventive Cardiology 2024 Congress in Salt Lake City, Utah.
AJMC Q&A with Dr Martha Gulati | Background image credit: ipopba – stock.adobe.com
August 2nd 2024

In ASPC President’s Address, Dr Martha Gulati Reflects on Progress and Future Goals in Cardiology

Hayden E. Klein
Martha Gulati, MD, MS, discusses the accomplishments of the American Society of Preventive Cardiology (ASPC) during her presidency and emphasizes the importance of advancing preventive cardiology.
Michael Shapiro, DO, FASPC, Wake Forest University and ASPC president elect
July 31st 2024

ASPC Congress to Highlight Innovations in CVD Prevention

Maggie L. Shaw
In advance of this year’s American Society for Preventive Cardiology (ASPC) 2024 Congress on CVD Prevention, we spoke with ASPC President-Elect Michael Shapiro, DO, FASPC, about the many can't-miss sessions at this year's record-breaking event.
concept of heart issues-ArtemisDiana-stock.adobe.com.jpeg
July 29th 2024

Applying PREVENT Equations May Reduce Statin and Antihypertensive Therapy for 15.8 Million US Adults

Pearl Steinzor
Researchers identify potential reductions in statin and antihypertensive therapy eligibility using Predicting Risk of cardiovascular disease EVENTs (PREVENT) equations.
MedDiet on table | Image credit: monticellllo - stock.adobe.com
July 25th 2024

Mediterranean Diet May Optimize Heart Health Among Children, Adolescents

Pearl Steinzor
Interventions promoting adherence to the Mediterranean diet were associated with cardiometabolic biomarkers in children and adolescents, according to one study.
Patient using a smartwatch | Image Credit: sitthiphong - stock.adobe.com
July 20th 2024

Wearable Devices Heighten Symptom Monitoring, Health Care Visits for Atrial Fibrillation

Brooke McCormick
Patients with atrial fibrillation who use wearable devices, like Apple Watches and FitBits, report higher anxiety levels and increased health care usage than nonusers.
Aspirin tablets dissolving in water | Imaged credit: Victor Moussa - stock.adobe.com
July 15th 2024

No Sex Differences Identified in Aspirin Dosing for Secondary Prevention of ASCVD

Pearl Steinzor
No significant differences in efficacy or safety of 2 aspirin doses were found between male and female patients for the secondary prevention of atherosclerotic cardiovascular disease (ASCVD).
Man investigating money with a magnifying glass | Image Credit: jirsak - stock.adobe.com
July 11th 2024

Study Finds Higher Health Care Expenditures for Patients With ASCVD, Diabetes

Brooke McCormick
Patients with both diabetes and atherosclerotic cardiovascular disease (ASCVD) have about 1.5 times higher total direct health care expenditures than those without diabetes.
ASPC Congress Logo
July 8th 2024

2024 ASPC Congress on CVD Prevention to Be Held in August

Maggie L. Shaw
The American Society for Preventive Cardiology (ASPC) 2024 Congress on CVD Prevention will take place August 2-4 in Salt Lake City, Utah.
Animated heart | Image Credit: - yodiyim - stock.adobe.com
July 4th 2024

GLP-1s Reduce Cardiovascular Risk Equally in Patients With Overweight, Obesity Regardless of Diabetes

Brooke McCormick
Glucagon-like peptide-1 (GLP-1) receptor agonists provide similar reductions in major adverse cardiovascular events, all-cause death, and cardiovascular-related death in patients with overweight and obesity who do not have diabetes and in patients with diabetes.
Air pollution | Image Credit: martin33 - stock.adobe.com
June 25th 2024

Air Pollution Linked to Increased Cardiovascular Disease Risk, Study Says

Brooke McCormick
Researchers discovered a causal relationship between air pollutants and increased cardiovascular disease (CVD) risk, highlighting the need for protective measures to mitigate exposure.
Health care cost concept | onephoto - stock.adobe.com
June 18th 2024

Home Heart Hospital Model Lowers Costs, Enhances Care for High-Cost Patients With CVD

Pearl Steinzor
The home-based care model offers a promising strategy for improving quality of care, while also reducing health care spending.
Hurricane damage to boats and shoreline | Macbeth GP - stock.adobe.com
June 12th 2024

How Climate Change Leads to Worse Cardiovascular Health

Pearl Steinzor
Extreme temperatures and hurricanes are strongly associated with worsening cardiovascular health, a study finds.
Xylitol sweetener | womue - stock.adobe.com
June 11th 2024

Sugar Substitute Xylitol Linked to Cardiovascular Risk

Pearl Steinzor
The low-calorie sweetener was associated with incident major adverse cardiovascular event risk, according to one study.
AJMC
June 10th 2024

Limited English Proficiency, Cardiovascular Risk Factors, Cardiovascular Disease, and In-Hospital COVID-19 Outcomes

Julia L. Berkowitz, MD Kevin F. Kennedy, MS Cristina Font, MD David R. Nerenz, PhD J. Dawn Abbott, MD Herbert D. Aronow, MD, MPH
This study evaluated whether limited English proficiency modifies the association between cardiovascular risk factors or cardiovascular disease and outcomes in patients hospitalized with COVID-19.
Magnesium pills | Image Credit: Dmitriy - stock.adobe.com
June 7th 2024

High Magnesium Depletion Scores Linked to Increased Mortality in US Patients With Hypertension

Brooke McCormick
Having a higher magnesium depletion score (MDS) independently predicts increased all-cause and cardiovascular mortality risks in US patients with hypertension (HTN), emphasizing the importance of early HTN prevention and magnesium deficiency management.
Center on Health Equity and Access
June 1st 2024

Health Equity and Access Weekly Roundup: June 1, 2024

Giuliana Grossi
This week, the Center on Health Equity and Access covers news related to AI integration, disparities in pediatric hospitalizations, new advancements presented at the 2024 CMS Health Equity Conference, and an expert discussion on the cardiovascular field.
Ronesh Sinha, MD | Image credit: Cardiometabolic Health Congress
May 31st 2024

Dr Ronesh Sinha Talks Digital Health Solutions to Combat Heart Disease Disparities

Hayden E. Klein Giuliana Grossi
Ronesh Sinha, MD, attributes the rising rates of heart disease to sedentary lifestyles, stress, and health inequities, while advocating for digital health solutions to improve preventive care.
AJMC
May 31st 2024

Modeling the Economic Value of Cardiometabolic Virtual-First Care Programs

Madison Noble, MPH Fang Chen, PhD Sarah Linke, PhD, MPH Timothy M. Dall, MS Jenna Napoleone, PhD, MPH
Using a microsimulation approach, this study modeled the potential multiyear health and economic benefits of participating in cardiometabolic virtual-first care programs.
<12345678
...
25>

259 Prospect Plains Rd, Bldg H,
Monroe, NJ 08831

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo